Dr. Bing Hu | Medicine | Best Researcher Award
Hearing Research at Shenzhen University, China
Dr. Bing Hu is a senior clinical otolaryngologist and postdoctoral fellow in Clinical Medicine at Sun Yat-sen University. With over 16 years of experience in the diagnosis, treatment, and surgical management of ENT (Ear, Nose, and Throat) diseases, Dr. Hu brings deep clinical knowledge and research expertise. He has been jointly trained by Xiangya Medical College and Case Western Reserve University (USA), and has held a visiting scholar position at the renowned Cleveland Clinic. His clinical proficiency, combined with an active role in medical research, has resulted in numerous national-level project participations and over 10 peer-reviewed publications.
Publication ProfileΒ
Educational Background π
-
Doctor of Medicine (M.D.)
Joint program by Case Western Reserve University (USA) & Xiangya Medical College (China) -
Ph.D. in Clinical Medicine
Sun Yat-sen University, China -
Postdoctoral Fellowship in Clinical Medicine
Sun Yat-sen University -
Clinical Training
-
Eye, Ear, Nose, and Throat Hospital, Fudan University
-
First Affiliated Hospital, Sun Yat-sen University
-
Professional Experience πΌ
-
Postdoctoral Fellow
Department of Clinical Medicine, Sun Yat-sen University -
ENT Specialist and Surgeon
Department of Otolaryngology β Head and Neck Surgery, Shenzhen Secondary Hospital & First Affiliated Hospital of Shenzhen University -
Visiting Scholar
Cleveland Clinic, USA -
Clinical Doctor (16 years experience)
-
Expertise in diagnosis and surgical management of ENT diseases
-
Practiced at multiple tier-one hospitals in China
-
Research Interests π¬
-
Otolaryngologic Diseases (ENT)
-
Minimally Invasive Endoscopic Surgery
-
Inflammatory and Infectious Diseases of the ENT System
-
Pediatric ENT Conditions (Adenoid Hypertrophy, Tonsillitis)
-
Surgical Management of Sinusitis, Rhinitis, Epistaxis
-
Clinical Outcomes and Patient-Centered Treatment Optimization
Awards and Honorsπβ¨
-
National Scholarship for Scholarly Exchange
Awarded for outstanding performance in international medical training and research -
Visiting Scholar Recognition
Cleveland Clinic β Recognized for advanced clinical research contributions -
Contributor and Investigator in Multiple Funded Projects
At national, provincial, and municipal levels
Conclusionπ
Dr. Bing Hu exemplifies the integration of clinical excellence with academic rigor. His dual training in China and the United States, along with his extensive surgical expertise and research involvement, position him as a leading figure in the field of otolaryngology. His continued work at the intersection of patient care and innovation ensures his lasting impact on ENT practice and education in China and beyond.
Publications π
-
π 3D UNet-based Abdominal Organ Automatic Segmentation Model using Image Denoising and Point Cloud Fusion
π° Alexandria Engineering Journal | π 2025
π¨βπ» Authors: Xue J., Hu B.
π Open Access -
𧬠Toe1 Promotes Proliferation and Differentiation of Neural Progenitor Cells
π° Heliyon | π 2024
π¨βπ» Authors: Deng T., Wu X., Wang Y., Fan X., Hu B.
π Cited: 1 -
π§ββοΈ BRCA1 Promotes Repair of DNA Damage in Cochlear Hair Cells and Prevents Hearing Loss
π° The Journal of Neuroscience | π 2024-09-03
π DOI: 10.1523/jneurosci.0132-24.2024
π¨βπ» Authors: Jiang W., Wang G., Bai F., Hu B., Xu Y., et al. -
π§ Advancements in Prevention and Intervention of Sensorineural Hearing Loss
π° Therapeutic Advances in Chronic Disease | π 2022-06-27
π DOI: 10.1177/20406223221104987
π¨βπ» Authors: Hong, Hu B., Jiang G.
π PMC: PMC9243368 -
πΏ Novel Application of Eupatilin for Effectively Attenuating Cisplatin-Induced Auditory Hair Cell Death via Mitochondrial Apoptosis Pathway
π° Oxidative Medicine and Cellular Longevity | π 2022-01-17
π DOI: 10.1155/2022/1090034
π PMC: PMC8786471 -
π©Ί Effectiveness of Salvage Intratympanic Dexamethasone Treatment for Refractory Sudden Sensorineural Hearing Loss Classified by Audiogram Patterns
π° Acta Oto-Laryngologica | π 2021-02-27
π DOI: 10.1080/00016489.2021.1889029 -
π Autophagy Impairment as a Key Feature for Acetaminophen-Induced Ototoxicity
π° Cell Death & Disease | π 2021-01-04
π DOI: 10.1038/s41419-020-03328-6
π PMC: PMC7791066 -
π¬ Liproxstatin-1 Protects Hair Cell-Like HEI-OC1 Cells and Cochlear Hair Cells against Neomycin Ototoxicity
π° Oxidative Medicine and Cellular Longevity | π 2020-12-01
π DOI: 10.1155/2020/1782659
π PMC: PMC7725559 -
βοΈ Ferrostatin-1 Protects Auditory Hair Cells from Cisplatin-Induced Ototoxicity In Vitro and In Vivo
π° Biochemical and Biophysical Research Communications | π 2020-10-24
π DOI: 10.1016/j.bbrc.2020.10.019 -
π± Otoprotective Effects of Stephania tetrandra S. Moore Herb Isolate against Acoustic Trauma
π° Journal of the Association for Research in Otolaryngology (JARO) | π 2018-09-05
π DOI: 10.1007/s10162-018-00690-3
π PMC: PMC6249158 -
𧬠Atoh1: Landscape for Inner Ear Cell Regeneration
π° Current Gene Therapy | π 2014
π DOI: 10.2174/1566523214666140310143407